Identification of chemokine receptors as potential modulators of endocrine resistance in oestrogen receptor–positive breast cancers

被引：0
|
作者：
Ricardo Ribas
Zara Ghazoui
Qiong Gao
Sunil Pancholi
Aradhana Rani
Anita Dunbier
Mitch Dowsett
Lesley-Ann Martin
机构：
[1] Breakthrough Breast Cancer Research Centre,Academic Department of Biochemistry
[2] Institute of Cancer Research,Department of Biochemistry
[3] Royal Marsden Hospital,undefined
[4] AstraZeneca,undefined
[5] Otago University,undefined
来源：
Breast Cancer Research | / 16卷
关键词：
Breast Cancer; Fulvestrant; CXCR7 Expression; Endocrine Resistance; Express Oestrogen Receptor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Endocrine resistance and epigenetic reprogramming in estrogen receptor positive breast cancer
    Dimitrakopoulos, Foteinos-Ioannis
    Kottorou, Anastasia
    Tzezou, Aspasia
    CANCER LETTERS, 2021, 517 : 55 - 65
  • [32] Overcoming endocrine resistance in hormone receptor-positive breast cancer
    AlFakeeh, A.
    Brezden-Masley, C.
    CURRENT ONCOLOGY, 2018, 25 : S18 - S27
  • [33] Tumour kinome re-wiring governs resistance to palbociclib in oestrogen receptor positive breast cancers, highlighting new therapeutic modalities
    Sunil Pancholi
    Ricardo Ribas
    Nikiana Simigdala
    Eugene Schuster
    Joanna Nikitorowicz-Buniak
    Anna Ressa
    Qiong Gao
    Mariana Ferreira Leal
    Amandeep Bhamra
    Allan Thornhill
    Ludivine Morisset
    Elodie Montaudon
    Laura Sourd
    Martin Fitzpatrick
    Maarten Altelaar
    Stephen R. Johnston
    Elisabetta Marangoni
    Mitch Dowsett
    Lesley-Ann Martin
    Oncogene, 2020, 39 : 4781 - 4797
  • [34] Tumour kinome re-wiring governs resistance to palbociclib in oestrogen receptor positive breast cancers, highlighting new therapeutic modalities
    Pancholi, Sunil
    Ribas, Ricardo
    Simigdala, Nikiana
    Schuster, Eugene
    Nikitorowicz-Buniak, Joanna
    Ressa, Anna
    Gao, Qiong
    Leal, Mariana Ferreira
    Bhamra, Amandeep
    Thornhill, Allan
    Morisset, Ludivine
    Montaudon, Elodie
    Sourd, Laura
    Fitzpatrick, Martin
    Altelaar, Maarten
    Johnston, Stephen R.
    Marangoni, Elisabetta
    Dowsett, Mitch
    Martin, Lesley-Ann
    ONCOGENE, 2020, 39 (25) : 4781 - 4797
  • [35] Implications of obesity and insulin resistance for the treatment of oestrogen receptor-positive breast cancer
    Javed, Sohail Rooman
    Skolariki, Aglaia
    Zameer, Mohammed Zeeshan
    Lord, Simon R.
    BRITISH JOURNAL OF CANCER, 2024, 131 (11) : 1724 - 1736
  • [36] Oestrogen receptor variant expression as potential selectors for adjuvant endocrine therapy in breast cancer patients
    Green, AR
    Paish, EC
    Gee, JM
    Nicholson, RI
    Cheung, KL
    Robertson, JF
    Ellis, IO
    JOURNAL OF PATHOLOGY, 2005, 205 : 5 - 5
  • [37] Impaired Succinate Metabolism Supports Endocrine Therapy Resistance in ER Positive Breast Cancers
    Yadav, Anil
    de Oliveira, Karla Andrade
    Jin, Lu
    Clarke, Robert
    Sengupta, Surojeet
    CANCER RESEARCH, 2023, 83 (05)
  • [38] ENDORSE: a prognostic model for endocrine therapy in estrogen-receptor-positive breast cancers
    Nath, Aritro
    Cohen, Adam L.
    Bild, Andrea H.
    MOLECULAR SYSTEMS BIOLOGY, 2022, 18 (06)
  • [39] PARP Inhibitors: A Major Therapeutic Option in Endocrine-Receptor Positive Breast Cancers
    Collet, Laetitia
    Peron, Julien
    Penault-Llorca, Frederique
    Pujol, Pascal
    Lopez, Jonathan
    Freyer, Gilles
    You, Benoit
    CANCERS, 2022, 14 (03)
  • [40] Structural underpinnings of oestrogen receptor mutations in endocrine therapy resistance
    John A. Katzenellenbogen
    Christopher G. Mayne
    Benita S. Katzenellenbogen
    Geoffrey L. Greene
    Sarat Chandarlapaty
    Nature Reviews Cancer, 2018, 18 : 377 - 388
12345